Participants’ characteristics (n = 26)
| Characteristic (assessed at cohort baseline) | n (%)a |
|---|---|
| Demographics | |
| Median age, years (range) | 55 (32–78) |
| Male, n (%) | 10 (38.5) |
| Median number of medications, n (range) | 4 (1–25) |
| Occupation, n (%) | |
| Working full time | 8 (30.8) |
| Working part time | 5 (19.2) |
| Retired | 6 (23.1) |
| Unable to work | 4 (15.4) |
| Home carer | 2 (7.7) |
| Unemployed | 1 (3.8) |
| Condition requiring OAT (%) | |
| Thrombosis | 11 (42.3) |
| Mechanical heart valve | 8 (30.8) |
| Atrial fibrillation | 4 (15.4) |
| Antiphospholipid syndrome | 3 (11.5) |
| Self-monitoring characteristics | |
| Median duration of self-monitoring, months (range) | 1.0 (1.0–6.3) |
| Received in-person self-monitoring training, n (%) | 19 (73.1) |
| Under care of an anticoagulation service, n (%) | 17 (65.4) |
| Median time in therapeutic range, % (range) | 82.7 (37.2–98.6) |
| Median oral anticoagulation knowledge score (range)b | 18 (12–20) |
| Dose adjustment status, n (%) | |
| Self-testing | 15 (57.7) |
| Self-managing | 8 (30.8) |
| Collaborative | 3 (11.5) |